Press Releases

Overview

Press Releases

Presentations

Stock Information

Filings

2024 – Press Releases

NetraMark provides business update and highlights progress

April 02, 2024 | NetraMark Holdings

NetraMark To Present New Data Highlighting The Utility Of Its AI Based Clinical Solution In Identifying Parkinson's Disease Associated Biomarkers At AD/PD™ 2024

February 29, 2024 | NetraMark Holdings

NetraMark To Present New Data Demonstrating The Power Of Its AI Based Technology To De-Risk Neurology Clinical Trials At ISCTM Annual Meeting

February 15, 2024 | NetraMark Holdings

NetraMark's Generative AI Discovers Novel Rare Disease Drug Targets and Unique Patient Subpopulations That Could Substantially Improve Clinical Trial Success Rates

January 16, 2024 | NetraMark Holdings

NetraMark signs contract with pharmaceutical company to deliver clinical trial insights regarding efficacy and placebo response

March 12, 2024 | NetraMark Holdings

NetraMark Signs Fourth Contract With Large Biopharmaceutical Company To Enhance Clinical Trial Insights

February 27, 2024 | NetraMark Holdings

NetraMark Announces Launch Of The Netra AI Lab

February 12, 2024 | NetraMark Holdings

NetraMark's Ai-based clinical solution identifies parkinson's disease subtypes linked by mitochondrial, microbiome and immune signaling

March 11, 2024 | NetraMark Holdings

NetraMark's AI Based Technology Identifies Significant Drivers Of Efficacy And Placebo Responses And Has Potential To Improve Success Rates For Clinical Trials Of Psychiatric Medications

February 26, 2024 | NetraMark Holdings

NetraMark Signs Third Contract With Large Biopharmaceutical Company to Enhance Clinical Trial Insights

January 30, 2024 | NetraMark Holdings

2023 – Press Releases

NetraMark Signs Two Contracts With Large Biopharmaceutical Company To Enhance Clinical Trial Insights

December 20, 2023 | NetraMark Holdings

NetraMark Signs Master Service Agreement With a Large Biopharmaceutical Company

October 31, 2023 | NetraMark Holdings

NetraMark Private Placement – Press Release Clarification

September 15, 2023 | NetraMark Holdings

NetraMark Announces Shares for Debt Settlement

July 5, 2023 | NetraMark Holdings

NetraMark Closes Second and Final Tranche of Private Placement

June 14, 2023 | NetraMark Holdings

NetraMark Announces Increase to Private Placement Financing

June 6, 2023 | NetraMark Holdings

NetraMark Selects Finn Partners As Its Public Relations Agency Of Record

November 20, 2023 | NetraMark Holdings

NetraMark Signs Master Service Agreement With a Large Biopharmaceutical Company

October 31, 2023 | NetraMark Holdings

NetraMark Announces Private Placement Financing

September 11, 2023 | NetraMark Holdings

NetraMark Enters into Advisor Agreement

June 22, 2023 | NetraMark Holdings

NetraMark Closes First Tranche of Private Placement

June 9, 2023 | NetraMark Holdings

NetraMark Announces Private Placement Financing

June 1, 2023 | NetraMark Holdings

Pharmaceutical Industry Veteran Joins NetraMark as Chief Medical Officer Joins

November 7, 2023 | NetraMark Holdings

NetraMark Closes Private Placement Financing

September 19, 2023 | NetraMark Holdings

Pharmaceutical Industry Veteran Joins NetraMark Advisory Board

July 19, 2023 | NetraMark Holdings

NetraMark Announces Engagement of ARU Global Inc.

June 21, 2023 | NetraMark Holdings

NetraMark Announces Uplist to the OTCQB Market

June 7, 2023 | NetraMark Holdings

NetraMark to Attend American Society of Clinical Oncology Conference in Chicago

June 1, 2023 | NetraMark Holdings